 |
Marc Shuman, MD
Recent Publications |
Publications – 2008 |
 |
Roy, S., S.A. Josephson, J. Fridlyand,
J. Karch, C. Kadoch, J. Karrim, L. Damon, P. Treseler, S.
Kunwar, M.A. Shuman, T. Jones, C.H. Becker, H. Schulman,
and J.L. Rubenstein, Protein biomarker identification in
the CSF of patients with CNS lymphoma. J Clin Oncol, 2008.
26(1): p. 96-105. |
| |
Publications – 2007 |
|
Rubenstein, J.L., J. Fridlyand, L. Abrey,
A. Shen, J. Karch, E. Wang, S. Issa, L. Damon, M. Prados,
M. McDermott, J. O'Brien, C. Haqq, and M.
Shuman, Phase I
study of intraventricular administration of rituximab in
patients with recurrent CNS and intraocular lymphoma. J Clin
Oncol, 2007. 25(11): p. 1350-6. |
| |
Publications – 2006 |
|
Chan, J.M., A. Feraco, M.
Shuman, and S.
Hernandez-Diaz, The epidemiology of prostate cancer--with
a focus on nonsteroidal anti-inflammatory drugs. Hematol
Oncol Clin North Am, 2006. 20(4): p. 797-809. |
|
Rubenstein, J.L., J. Fridlyand, A. Shen,
K. Aldape, D. Ginzinger, T. Batchelor, P. Treseler, M. Berger,
M. McDermott, M. Prados, J. Karch, C. Okada, W. Hyun, S.
Parikh, C. Haqq, and M. Shuman, Gene expression and angiotropism
in primary CNS lymphoma. Blood, 2006. 107(9): p. 3716-23. |
return
to top
|
|
|
|
|
|
